ELEVATEBIO Trademark

Trademark Overview

On Wednesday, October 17, 2018, a trademark application was filed for ELEVATEBIO with the United States Patent and Trademark Office. The USPTO has given the ELEVATEBIO trademark a serial number of 88157955. The federal status of this trademark filing is REGISTERED as of Tuesday, October 5, 2021. This trademark is owned by ElevateBio, LLC. The ELEVATEBIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of cancer; Research and development of medicines; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research services in the field of cancer; Pharmaceutical research and development; Providing laboratory research services in the field of gene expression, namely, cancer biology; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Stem cell research services; Testing, inspection, research, or development...
elevatebio

General Information

Serial Number88157955
Word MarkELEVATEBIO
Filing DateWednesday, October 17, 2018
Status700 - REGISTERED
Status DateTuesday, October 5, 2021
Registration Number6511815
Registration DateTuesday, October 5, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 19, 2019

Trademark Statements

Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of cancer; Research and development of medicines; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research services in the field of cancer; Pharmaceutical research and development; Providing laboratory research services in the field of gene expression, namely, cancer biology; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Stem cell research services; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Pseudo MarkELEVATE BIO

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, October 27, 2018
Primary Code042
First Use Anywhere DateThursday, July 25, 2019
First Use In Commerce DateThursday, July 25, 2019

Trademark Owner History

Party NameElevateBio, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02142
Party NameElevateBio, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02142
Party NameElevateBio, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Tuesday, October 5, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, August 31, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, August 30, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, July 22, 2021STATEMENT OF USE PROCESSING COMPLETE
Thursday, July 15, 2021USE AMENDMENT FILED
Thursday, July 15, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, June 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 21, 2021EXTENSION 2 GRANTED
Wednesday, May 12, 2021EXTENSION 2 FILED
Tuesday, June 15, 2021NOTICE OF REVIVAL - E-MAILED
Tuesday, June 15, 2021EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, June 15, 2021PETITION TO REVIVE-GRANTED
Tuesday, June 15, 2021TEAS PETITION TO REVIVE RECEIVED
Monday, June 14, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 14, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, June 10, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 10, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 10, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 17, 2021EXTENSION 1 GRANTED
Thursday, November 12, 2020EXTENSION 1 FILED
Monday, March 15, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 14, 2020NOTICE OF REVIVAL - E-MAILED
Monday, December 14, 2020EXTENSION RECEIVED WITH TEAS PETITION
Monday, December 14, 2020PETITION TO REVIVE-GRANTED
Monday, December 14, 2020TEAS PETITION TO REVIVE RECEIVED
Monday, December 14, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 14, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 12, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, May 12, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 12, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 12, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 12, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 12, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, April 2, 2020TTAB RELEASE CASE TO TRADEMARKS
Thursday, April 2, 2020OPPOSITION TERMINATED NO. 999999
Thursday, April 2, 2020OPPOSITION DISMISSED NO. 999999
Monday, September 16, 2019OPPOSITION INSTITUTED NO. 999999
Monday, July 22, 2019ASSIGNED TO EXAMINER
Tuesday, April 16, 2019EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, March 19, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 19, 2019PUBLISHED FOR OPPOSITION
Wednesday, February 27, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 5, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 28, 2019ASSIGNED TO EXAMINER
Saturday, October 27, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, October 20, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

elevatebio research development cancer services medical field pharmaceutical scientific biotechnology fields